New antibacterial therapeutics and strategies

• Autorzy: Kurek A. , Grudniak A.M. , Kraczkiewicz-Dowjat A. , Wolska K.I.
• Języki publikacji: EN

Abstrakty

EN

Studies on new antibacterial therapeutics and strategies are currently being conducted in many microbiological, pharmaceutical and biochemical laboratories. The antibacterial activity of plant-derived compounds as well as silver and gold nanoparticles is the subject of this minireview. The application of photodynamic therapy is also discussed.

Słowa kluczowe

EN

antimicrobial agent; nanoparticle; new antimicrobial agent; photodynamic therapy; phytotherapy; plant compound; plant metabolite; secondary metabolite; terpene; phenolics; polyphenol; dye; natural dye; synthetic dye

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2011
• Tom: 60
• Numer: 1
• Opis fizyczny: p.3-12,fig.,ref.

Twórcy

autor

Kurek A.

• Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland

autor

Grudniak A.M.

autor

Kraczkiewicz-Dowjat A.

autor

Wolska K.I.

Bibliografia

• Ahmed A.A., A.A. Mahmoud, H.J. Williams, A.I. Scott, J.H. Reinbenspiesand and T.J. Mabry. 1993. New sesquiterpene α-methylene lactones from the Egyptian plant Jasonia candicans. J. Nat. Prod. 56: 1276-1280.
• Allaker R.P. 2010. The use of nanoparticles to control oral biofilm formation. J. Dent. Res. 89: 1175-1186.
• Amaral J.A., A. Ekins S.R. Richards and R. Knowles. 1998. Effect of selected monoterpenes on methane oxidation, denitrification, and aerobic metabolism by bacteria in pure culture. Appl. Environ. Microbiol. 64: 520-525.
• Baker C., A. Pradhan, L. Pakstis, D.J. Pochan and S.I. Shah. 2005. Synthesis and antibacterial properties of silver nanoparticles. J. Nanosci. Nanotechnol. 5: 244-249.
• Baptista P.V., M. Koziol-Montewka, J. Paluch-Oles, G. Doria and R. Franco. 2006. Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin. Chem. 52: 1433-1434.
• Baron S. and J.J. Rove. 1981. Antibiotic action of pyocyanin. Antimicrob. Agents Chemother. 20: 814-830.
• Borges F., F. Roleira, N. Mihazes, L. Santana and E. Uriarte. 2005. Simple coumarins and analogues in medical chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem. 12: 887-916.
• Borris R.P. 1996. Natural products research: perspectives from a major pharmaceutical company. J. Ethnopharmacol. 51: 29-38.
• Brantner A., Ž. Maleš, S. Pepelnjak and A. Antolić. 1996. Antimicrobial activity of Paliurus spina-christi Mill. (Christ's thorn). J. Ethnopharmacol. 52: 119-122.
• Burygin G.L., B.N. Khlebtstov, A.N. Shantrokha, L.A. Dykman, V.A. Bogatyrev and N.G. Khlebtsov. 2009. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res. Lett. 4: 794-801.
• Cabrera C., R. Artacho and R. Giménez. 2006. Beneficial effect of green tea a review. J. Am. Coll. Nutr. 25: 79-99.
• Castellano J.J., S.M. Shafii, F. Ko, G. Donate, T.E. Wright, R.J. Mannari, W.G. Payne, D.J. Smith, M.C. Robson. 2007. Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int. Wound J. 4: 114-122.
• Cazarolli L.H., L. Zanatta, E.H. Alberton, M.S. Figueiredo, P. Folador, R.G. Damazio, M.G. Pizzolatti and F.R. Silva. 2008. Flavonoids: prospective drug candidates. Mini Rev. Med. Chem. 8: 1429-1440.
• Cechinel Filho V., C. Meyre-Silva and R. Neiro. 2009. Chemical and pharmacological aspects of the genus Calophyllum. Chem. Biodivers. 6: 313327.
• Chen J.-C., T.-H. Ho, Y.-S. Chang, S.-L. Wu, C.-C. Li and C.-Y. Hsiang. 2009. Identification of Escherichia coli enterotoxin inhibitors from traditional medical herbs in silico, in vitro and in vivo analyses. J. Ethnopharmacol. 121: 372-378.
• Chibani-Chennoufi S., J. Sidoti, A. Bruttin, E. Kutter, S. Sarker and H. Brussow. 2004. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48: 2558-2569.
• Chopra I. 2007. The increasing use of silver-based products as antimicrobial agents: a useful development or a case for concern? J. Antimicrobial. Chem. 59: 587-590.
• Chung K.T., T.Y. Wong, C.I. Wei, Y.W. Huang and Y. Lin. 1998. Tannins and human health: a review. Crit. Rev. Food Sci. Nutr. 38: 421-464.
• Cimolai N. and T. Cimolai. 2007. The cranberry and urinary tract. Eur. J. Clin. Microbiol. Infect. Dis. 26: 767-776.
• Comini L.R., S.C. Núňez Montoya, P.L. Páez, G.A. Argüello, I. Albesa and J.L. Cabrera. 2010. Antibacterial activity of anthraquinone derivatives from Heterophyllaea postulate (Rubiaceae). J. Photochem. Photobiol. B.
• Copp B.R. and A.N. Pearce. 2007. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat. Prod. Rep. 24: 278-297.
• Cortivo R., V. Vindigni, L. Iacobellis, G. Abatangelo, P. Pinton and B. Zavan. 2010. Nanoscale particle therapies for wounds and ulcers. Nanomedicine 5: 641-656.
• Cowan M.M. 1999. Plant product as antimicrobial agents. Clin. Microbiol. Rev. 12: 564-582.
• Dai T., Y.-Y. Huang and M.R. Hamblin. 2009. Photodynamic therapy for localized infections state of art. Photodiag. Photodyn. Ther. 6: 170-188.
• Dastjerdi R. and M. Montazer. 2010. A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloids Surf. B. Interfaces. 79: 5-18.
• de la Iglesia R., F.I. Milagro, J. Campión, N. Boqué and J.A. Martinez. 2010. Healthy properties of proanthocyanidins. Biofactors 36: 159-168.
• Demidova T.N. and M.R. Hamblin. 2005. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob. Agents Chemother. 49: 2329-2335.
• Donadio S., S. Maffiolo, P. Monciardini, M. Sosio and D. Jabes. 2010. Antibiotic discovery in the twenty-first century: current trends and future perspectives. J. Antibiot. (Tokyo) 63: 423-430.
• Dryden G.W., M. Song and C. McClain. 2006. Polyphenols and gastrointestinal diseases. Curr. Opin. Gastroenterol. 22: 165-170.
• Edwards-Jones V. 2009. The benefits of silver in hygiene, personal care and healthcare. Lett Appl. Microbiol. 49: 147-152.
• Elghanian R., J.J. Storhoff, R.C. Mucic, R.L. Letsinger and C.A. Mirkin. 1997. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277: 1078-1081.
• Farina C., M. Pinza and G. Pifferi. 1998. Synthesis and antiulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. Pharmacology 53: 22-32.
• Feng Q.J., J. Wu, G.Q. Chen, F.Z. Cui, T.N. Kim and J.Q. Kim. 2000. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphyloccocus aureus. J. Biomed. Matter 52: 662-668.
• Fontanay S., M. Grare, J. Mayer, C. Finance and R.E. Duval. 2008. Ursolic, oleanolic and betulic acids: Antibacterial spectra and selectivity indexes. J Ethnopharmacol. 120: 272-276.
• Friedman M. 2007. Overwiew of antibacterial, antitoxin, antiviral and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 51: 116-134.
• Gad F., T. Zahra, T. Hasan and M.R. Hamblin. 2004. Effect of growth phase and extracellular slime on photodynamic inactivation of Gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 48: 2173-2178.
• Gade A.K., P. Bonde, A.P. Ingle, P.D. Marcato, N. Duran and M.K. Rai. 2008. Explotation of Aspergillus niger for synthesis of silver nanoparticles. J. Biol. Mater. Bioener. 2: 1-5.
• Ge F., F. Zeng, S. Liu, N. Guo, H. Ye, Y. Song, J. Fan, X. Wu, X. Wang, X. Deng, Q. Jin and L. Yu. 2010. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J. Med. Microbiol. 59: 567-72.
• Gil-Thomás J., S. Tubby, I.P. Parkin, N. Narband, L. Dekker, S.P. Nair, M. Wilson and C. Street. 2007. Lethal photosensitisation of Staphylococcus aureus using toluidine blue O-tiopronin-gold nanoparticle conjugate. J. Mat. Chem. 17: 3739-3746.
• Górski A., A. Międzybrodzki, J. Borysowski, B. Weber-Dąbrowska, M. Łobocka, W. Fortuna, S. Letkiewicz, M. Zimecki and G. Filby. 2009. Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig. Drugs 10: 766-774.
• Grace N.A. and K. Pandian. 2007. Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles - A brief study. Colloids Surf. A Physicochem. Eng. Asp. 297: 63-70.
• Griffiths M.A., B.W. Wren and M. Wilson. 1997. Killing of methicillin-resistant Staphylococcus aureus in vitro using aluminium disulphonated phthalocyanine, a light-activated antimicrobial agent. J. Antimicrob. Chemother. 40: 873-876.
• Gu H., P.L. Ho, E. Tong, L. Wang, B. Xu. 2003. Presentation of vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 3: 1261-1263.
• Gurunathan S., K. Kaliswaralal, R. Vaidyanathan, D. Venkataraman, S.R. Pandian, J. Hariharan and S.H. Eom. 2009. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surf. B. Interfaces 74: 328-335.
• Habtermariam S., A.I. Gray and P.G. Waterman. 1993. A new antibacterial sesquiterpene from Premna oligotricha. J. Nat. Prod. 56: 140-143.
• Hamblin M.R., J. Viveiros, C.H. Yang, A. Ahmadi, R.A. Ganz and M.J. Tolkoff. 2005. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob. Agents Chemother. 49: 2822-2827.
• Harada H. and N. Misawa. 2009. Novel approaches and achievements in biosynthesis of functional isoprenoids in Escherichia coli. Appl. Microbiol. Biotechnol. 84: 1021-1031.
• Hatano T., M. Kusuda, K. Inada, T.O. Ogawa, S. Shiota, T. Tsuchiya and T. Yoshida. 2005. Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry 66: 2047-2055.
• He S., Y. Zhang, Z. Guo and N. Gu. 2008 . Biological synthesis of gold nanowires using extact of Rhodopseudomonas capsulata. Biotech. Prog. 24: 476-480.
• Hillard E.A., F.C. de Abreu, D.C. Ferreira, G. Jaouen, M.O. Goulart, C. Amatore. 2008. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. Chem Commun. (Camb.) 21: 2612-2628.
• Högberg L. D., A. Heddini and O. Cars. 2010. The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol. Sci. 31: 509-515.
• Ingle A., A. Gade, S. Pierrat, C. Sonnichsen and M. Rai. 2008. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr. Nantechnol. 4: 141-144.
• Jain P. and T. Pradeep. 2005. Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol. Bioeng. 90: 59-63.
• Jones G.A., T.A. McAllister, A.D. Muir and K.J. Cheng. 1994. Effects of sainfoin (Onobrychis viciifolia Scop.) condensed tannins on growth and proteolysis by four strains of ruminal bacteria. Appl. Environ. Microbiol. 60: 1374-1378.
• Jun J., D. Yuan-Yuan, W. Shao-feng, W. Zhong-yi. 2007. Preparation and characterization of antibacterial silver-containing nanofibers for wound dressing applications. J. US-China Med. Sci. 4: 52-54.
• Kaittanis C., S. Santra and J.M. Perez. 2010. Emerging nanotechnology based strategies for the identification of microbial pathogenesis. Adv. Drug Deliv. Rev. 62: 408-423.
• Kalishwaralal K., S. BarathManiKanth, S.R. Pandian, V. Deepak and S. Gurunathan. 2010. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Sur. B Biointerfaces 79: 340-344.
• Kazumi M.H., A. Malik, S. Hammed, N. Akhtar and S. Noor Ali. 1994. An anthraquinone derivative from Cassia italica. Phytochemistry 36: 761-763.
• Kim J.S., E. Kuk, K.N. Yu, J.H. Kim, S.J. Park, H.J. Lee, S.H. Kim,. Y.K. Park, C.Y. Hwang, Y.K. Kim, Y.S. Lee, D.H. Jeong and M.H. Cho. 2007. Antimicrobial effect of silver nanoparticles. Nanomedicine 3: 95-101.
• Koleckar V., K. Kubikova, Z. Rehakova, K. Kuca, D. Jun, L. Jahodar and L. Opletal. 2008. Condensed and hydrolysable tannins as antioxidants influencing the health. Mini Rev. Med. Chem. 8: 436-447.
• Koo M.W. and C.H. Cho. 2004. Pharmacological effect of green tea on the gastrointestinal system. Eur. J. Pharmacol. 500: 177-185.
• Koru O., F. Toksoy, C.H. Acikel, Y.M. Tunca, M. Baysallar, A. Uskudar Guculu, E. Akca, A. Ozkok Tuylu, K. Sorkun, M. Tanyuksel and B. Salih. 2007. In vitro antimicrobial activity of propolis samples from different geographical origins against certain oral pathogens. Anaerobe 13: 140-145.
• Koyama J. 2006. Anti-infective quinone derivatives of recent patents. Recent Pat. Antiinfect. Drug Discov. 1: 113-125.
• Kozai K., J. Suzuki, M. Okada and N. Nagasaka. 1999. Effect of oleanolic acid-cyclodextrin inclusion compounds on dental carries by in vitro experiment in rat-carries model. Microbios 97: 179-188.
• Krokosz A. 2007. Fullerenes in biology (in Polish). Post. Biochem. 53: 91-96.
• Kubo I., H. Muroi and M. Himejima. 1992. Antibacterial activity of totarol and its potentiation. J. Nat. Prod. 55: 1436-1440.
• Kumar A., P. K. Vemula, P. M. Ajayan and G. John. 2008. Silver nanoparticle-embeded antimicrobial paints based on vegetable oil. Nat. Mater. 7: 236-241.
• Kurek A., A.M. Grudniak, M. Szwed, A. Klicka, Ł. Samluk and K.I. Wolska. 2010. Oleanolic acid and ursolic acid affect peptidoglycan metabolism in Listeria monocytogenes. Anton, Leuven. 97: 1143-1146.
• Kuźma Ł., M. Różalski, E. Walencka, B. Różalska and H. Wysokińska. 2007. Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine 14: 31-35.
• Lakatoš B., B. Kaliňková, D. Hudecová. and L. Varečka. 2010. New effect and applications of thioflavins. Centr. Eur. J. Biol. 5: 143-150.
• Landsdown A.B. 2006. Silver in health care: antibacterial effect and safety in use. Curr. Probl. Dermatol. 33: 17-34.
• Leon L.L., C.C. Miranda, A.O. De Souza and N. Durán. 2001. Antleishmanial activity of the violacein extracted from Chromobacterium violaceum. J. Antimicrob. Chemother. 48: 449-450.
• Levy S.B. 1998. The challenge of antibiotics resistance. Sci. Am. 278: 46-53.
• Li Y., P. Leung, Q.W. Song and E. Newton. 2006. Antimicrobial effect of surgical masks coated with nanoparticles. J. Hosp. Infect. 62: 58-63.
• Li Q., S. Mahendra, D.Y. Lyon, L. Brunet, M.V. Liga, D. Li and P.J. Alvarez. 2008. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res. 42: 4591-4602.
• Li H.Q., L. Shi, Q. S. Li, P.G. Liu, Y. Luo, J. Zhao and H.L. Zhu. 2009. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthetase III (FabH) as antibiotics. Bioorg. Med. Chem. 17: 6264-6269.
• Liu P.F., W.H. Zhu and C.M. Huang. 2009. Vaccines and photodynamic therapies for oral microbial-related diseases. Curr. Drug. Metab. 10: 90-94.
• Liu J. 2005. Oleanolic and ursolic acids: Research perspectives. J. Ethnopharmacol. 100: 92-94.
• Lok Ch-M., Ch-M. Ho, R. Chen, Q-Y. He, W-Y. Yu, H. Sun, Kwong-Hang, P. Tam, J-F. Chiu and Ch-M. Chi-Ming Che. 2006. Proteomic analysis of the mode of antimicrobial action of silver nanoparticles. J. Prot. Res. 5: 916-924.
• Maisch T., C. Bosi, R.M. Szeimies, N. Lehn and C. Abels. 2005. Photodynamic effect of novel XF porfyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemother. 49: 1542-1552.
• Males Z., A.H. Branter, K. Sović, K.H. Pilepić and M. Plazibat. 2006. Comparative phytochemical and antimicrobial investigations of Hypericium perforatum L. subsp. perforatum and H. perforatum subsp. angustifolium (DC.) Gaudin. Acta Pharm. 56: 359-367.
• Mason T.L. and B.P. Wasserman. 1987. Inactivation of red beet beta-glucan synthetase by native and oxidized phenolic compounds. Phytochemistry 26: 2197-2202.
• Minnock A., D.I. Vernon, J. Schofield., J. Griffith., J. Howard Parish and S.B. Brown. 1996. Photoinactivation of bacteria. Use of cationic water-soluble zinc phthalocyanine to photoinactivate both Gram-negative and Gram-positive bacteria. J. Photochem. Photobiol. B. Biol. 32: 159-64.
• Monteiro D.R., L.P. Gorup, A.S. Takamiya, A.C. Ruvollo-Filho, E.R. de Camargo and D. Barros Barbosa. 2009. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int. J. Antimicrob. Agents 34: 103-110.
• Morones J.R., J.L. Elechigerra, A. Camacho and J.T. Ramirez. 2005. The bacterial effect of silver nanoparticles. Nanotechnology 16: 2346-2353.
• Mourer M., H.M. Dibama, S. Fontanay, M. Grare, R.E. Duval, C. Finance and J.B. Regnouf-de-Vains. 2009. p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation. Bioorg. Med. Chem. 17: 5496-5509.
• Myles D.C. 2003. Novel biologically active natural and unnatural products. Curr. Opin. Biotechnol. 14: 627-633.
• Nakayama T., T. Hashimoto, K. Kajiyaand S. Kumazawa. 2000. Affinity of polyphenols for lipid bilayers. Biofactors 13: 147-151.
• Nakahara K., S. Kawabata, H. Ono, K. Ogura, T. Tanaka, T. Ooshima and S. Hamada. 1993. Inhibitory effect of oolong tea polyphenols on glucosyltransfrases of mutant streptococci. Appl. Environ. Microbiol. 59: 968-973.
• Narayanan K.B. and N. Sakthivel. 2010. Biological synthesis of metal nanoparticles by microbes. Adv. Colloid Sci. 156: 1-13.
• Neal A.I. 2008. What can be inferred from bacterium - nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Exotoxicobiology 7: 362-371.
• Nisnevitch M., F. Nakonechny and Y. Nitzan. 2010. Photodynamic antimicrobial chemotherapy by liposome-encapsulated water-soluble photosensitizers. Bioorg. Chim. 36: 396-402.
• Norman R.S., J.W. Stowe, A. Gole, C.J. Murphy and T.L. Sabo-Altwood. 2008. Targeted photothermal lysis of pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano. Lett. 8: 302-306.
• Okuda T. 2005. Systematics and health effects of chemically distinct tannins in medical plants. Phytochemistry 66: 2012-2031.
• Pal S., Y.K. Tak and J.M. Song. 2007. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 27: 1712-1720.
• Panacek A., L. Kvitek, R. Prucek, M. Kolar, R. Vecerova and N. Pizurova. 2006. Silver colloid nanoparticles: synthesis, characterization and their antibacterial activity. J. Phys. Chem. 110: 16248-16243.
• Perni S., C. Piccirillo, J. Pratten, P. Prokopovich, W. Chrzanowski, P. Parkin and M. Wilson. 2009. The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles. Biomaterials 30: 89-93.
• Pissuwan D., C.H. Cortie, S.M. Valenzuela and M.B. Cortie. 2009. Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol. 28: 207-213.
• Pitsillides C.M., E.K. Joe, X Wei, R.R. Anderson and C.P. Lin. 2003. Selective cell targeting with light-absorbing microparticles with nanoparticles. Biophys. J. 84: 4023-4032.
• Pommier Y., E. Leo, H. Zhang and C. Marchand. 2010. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 28: 421-433.
• Rai M., A. Yadav and A Gade. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotech. Adv. 27: 76-83.
• Rallis E. and E. Koumantaki-Mathioudaki. 2007. Treatment of Mycobacterium marinum cutaneous infections. Expert Opin. Pharmacother. 8: 2965-2978.
• Ren D., R. Zuo, A.F. Gonzalez Barrios, L.A. Bedzyk, G.R. Eldridge, M.E. Pasmore and T.K. Wood. 2005. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl. Environ. Microbiol. 71: 4022-4034.
• Rios J.L. and M.C. Recio. 2005. Medical plants and antimicrobial activity. J. Ethnopharmacol. 100: 80-84.
• Rosemary M.J., I. MacLaren and T. Pradeep. 2006. Investigations of the antibacterial properties of ciprofloxacin SiO₂. Langmuir 22: 10125-10129.
• Ryskova L., V. Buchta and R. Slezak. 2010. Photodynamic antimicrobial therapy. Centr. Eur. J. Biol. 5: 400-406.
• Sacchettini J.C. and C.D. Poulter. 1997. Creating isoprenoid diversity. Science 277: 1788-1789.
• Saddiqe Z., I. Naeem and A. Maimoona. 2010. A review of the antibacterial activity of Hypericum perforatum L. J. Ethnopharmacol. 131: 511-521.
• Saji M., S. Taguchi, K. Uchiyama, E. Osomo, N. Hayama and H. Ohkumi. 1995. Efficacy of gentian-violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J. Hosp. Infect. 31: 225-228.
• Sakanaka S., N. Shimura, M. Aizawa, M. Kim and T. Yamamoto. 1992. Preventive effect of green tea polyphenols against dental caries in conventional rats. Biosci. Biotechnol. Biochem. 56: 592-594.
• Savluchinske-Feio S., M.J. Curto, B. Gigante and J.C. Roseiro. 2006. Antimicrobial activity of resin acid derivatives. Appl. Microbiol. Biotech. 72: 430-436.
• Shahverdi A.R., A. Fakhimi, H.R. Shahverdi and S.M. Minaian. 2007. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 3: 168-171.
• Shang X., X. He, M. Li, R. Zhang, P. Fan, Q. Zhang and Z. Jia. 2010. The genus Scutellaria an ethnopharmacological and phytochemical review. J. Ethnopharmacol. 128: 279-313.
• Sharma V.K., R.A. Yngard and Y. Lin. 2009. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 145: 83-96.
• Simon-Deckers A., S. Loo, M. Mayne-L'hermite, N. Herlin-Boime, N. Menguy, C. Reynaud, B. Gouget and M. Carriere. 2009. Size-, composition-, and shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes towards bacteria. Environ. Sci. Technol. 43: 8423-8429.
• Singh M., S. Singh, S. Prasada and I.S. Gambhir. 2008. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Digest J. Nanomat. Biostruct. 3: 115-122.
• Smith E., E. Williamson, M. Zloh and S. Gibbons. 2005. Isopimaric acid from Pinus nigra shows activity against multidrugresistant and EMRSA strains of Staphylococcus aureus. Phytother. Res. 19: 538-542.
• Soncin M., C. Fabris, A. Busetti, D. Dei, D. Nistri and G. Roncucci. 2002. Approaches to selectivity in the Zn (II)-phthalocyanide-photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem. Photobiol. Sci. 1: 815-819.
• Sondi J. and B. Salopek-Sondi. 2004. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gramnegative bacteria. J. Colloid Interface 275: 177-182.
• Storhoff J.J., A.D. Lucas, V. Garimella, Y.P. Bao and U.R. Müller. 2004. Homogenous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticles probes. Nat. Biotechnol. 22: 883-887.
• Suresh Babu K., T. Hari Babu, P.V. Srinvas, K. Hara Kishore, U.S. Murthy and J.M. Rao. 2006. Synthesis and biological evaluation of novel C(7) modified chrysin analogues as antibacterial agents. Bioorg. Med. Chem. Lett. 16: 221-224.
• Tom R.T., V. Suryanarayanan, P.G. Reddy, S. Baskaran and T. Pradeep. 2004. Ciprofloxacin-protected gold nanoprticles. Langmuir 20: 1909-1914.
• Tomi N.S., B. Kranke and W. Aberer. 2004. A silver man. Lancet 363: 532.
• Tsuchiya H., M. Sato, M. Miyazaki, S. Fuijwara, S. Tanigaki, M. Ohyama, T. Tanaka, and M. Iinuma. 1996 Comparative study on the antibacterial activity of photochemical flavanones against meticillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 50: 27-34.
• Unno N., M. Suzuki, N. Yamamoto, K. Inuzuka, D. Sagara and M. Nishiyama. 2008. Indocyanine green fluorescence angiography for intraoperative assessment of blond flow: a feasibility study. Eur. J. Vasc. Endovasc. Surg. 35: 205-207.
• Urs N.V.R.R. and J.M. Dunleavy. 1975. Enhancement of the bactericidal activity of peroxidase system by phenolic compounds (Xanthomonas phaseoli var. sojensis, soybeans). Phytopathology 65: 686-690.
• Uzel A., K. Sorkun, O. Onçag, D. Cogülu, O. Gençay and B. Salih. 2005. Chemical composition and antimicrobial activities of four different Anatolian propolis samples. Microbiol. Res. 160: 189-195.
• Vaidyanathan R., S. Gopalram, K. Kalishwaralal, V. Deepak, S.R. Pandian and S. Gurunathan. 2010. Enhanced silver nanoparticle synthesis by optimization of nitrate reductase activity. Colooids Sur. B Biointerfaces 75: 335-341.
• Valodkar M., A. Bhadoria, J. Pohnerkar, M. Mohan and S. Thakore. 2010. Morphology and antibacterial activity of carbohydrate-stabilized silver nanoparticles. Carbohydr. Res. 345: 1767-1773.
• Veigas B., D. Machado, J. Perdigao, I. Portugal, I. Couto, M. Viveiros and P.V. Baptista. 2010. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology 21: 415101.
• Vijaya K., S. Ananthan and R. Nalini. 1995. Antibacterial effect of teaflavin, polyphenon 60 (Camellia sinensis) and Euphorbia hirta on Shigella spp. - a cell culture study. J. Ethnopharmacol. 49: 115-118.
• Wainwright M. 2008. Dyes in the development of drugs and pharmaceuticals. Dyes Pigments 76: 582-589.
• Wainwright M. 2010. Safe photoantimicrobials for skin and soft-tissue infections. Int. J. Antimicrob. Agents 36: 14-18.
• Walencka E., S. Różalska, S. Wysokińska, M. Różalski, L. Kuźma and B. Różalska. 2007. Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotics resistance and express anti-biofilm activity. Planta Med. 73: 545-551.
• Wang X., L.H. Liu, O. Ramström and M. Yan. 2009. Engineering nanomaterial surfaces for biomedical applications. Exp. Biol. Med. 234: 1128-1139.
• Wangoo N., K.K. Bhasin, R. Boro and C.R. Suri. 2008. Facile synthesis and functionalization of water-soluble gold nanoparticles for bioprobe. Anal. Chim. Acta 610: 142-148.
• Wansi J.D., D.D. Chiozem, A.T. Tcho, F.A. Toze, K.P. Devkota, B.L. Ndjakou, J. Wandji and N. Sewland. 2010. Antimicrobial and antioxidant effects of phenolic constituents from Klainedoxa gaboniensis. Pharm. Biol. 48: 1124-1129.
• Wolska K.I., A.M. Grudniak, B. Fiecek, A. Kraczkiewicz-Dowjat and A. Kurek. 2010 a. Antibacterial activity of oleanolic and ursolic acids and their derivatives. Centr. Eur. J. Biol. 5: 543-553.
• Wolska K.I., A.M. Grudniak, A. Kraczkiewicz-Dowjat and A. Kurek. 2010 b. Various functions of selected bacterial pigments (in Polish). Post. Mikrobiol. 40: 105-114.
• Wood S., D. Metcalf, D. Devine and R. Robinson. 2006. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother. 57: 680-684.
• Wright G.D. 2010. Antibiotic resistance in the environment: a link to the clinic? Curr. Opin. Microbiol. 13: 589-594.
• Yoon K-Y, J.H. Byeon, J.-H. Park and J. Hwang. 2007. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci. Tot. Environm. 373: 572-575.
• Zharov V.P., E.I. Galanzha and W. Tuchin. 2007. Photothermal flow cytometry in vitro for detection and imaging of individual moving cells. Cytometry A 71: 191-206.
• Zharov V.P., K.E. Mercer, E.N. Galitovskaya and M.S. Smeltzer. 2006. Photothermal nanotherapeutics for selective killing of bacteria targeted with gold nanoparticles. Biophys. J. 90: 619-627.
• Zhang Y., F. Bao, J. Hu, S. Liang, Y. Zhang, G. Du, C. Zhang and Y. Chen. 2007. Antibacterial ligands and triterpenoids from Rostellularia procumbens. Planta Med. 73: 1596-1599.